Indicators used in study
| Aspirin therapy for high risk patients (45–69 years) |
| % of population with a diagnosis of ischaemic heart disease (IHD) |
| % of population with a diagnosis of IHD who take aspirin |
| % of population with a diagnosis of ischaemic stroke or transient ischaemic attacks (TIAs) |
| % of population with a diagnosis of stroke or TIAs who take aspirin |
| Detection and control of hypertension (45–69 years) |
| % of population who have had their BP recorded in the previous five years |
| % of population with a diagnosis of hypertension |
| % of population identified as hypertensive whose most recent systolic BP is less than 160 mm Hg |
| % of population identified as hypertensive whose most recent diastolic BP is less than 90 mm Hg |
| % of population identified as hypertensive who have had their BP recorded in the previous year |
| % of those with a diagnosis of IHD who have had their BP recorded in the previous year |
| % of those with a diagnosis of ischaemic stroke or TIA who have had their BP recorded in the previous year |
| % of population with a diagnosis of diabetes mellitus |
| % of those identified with diabetes mellitus whose most recent systolic BP is less than 160 mm Hg |
| % of those identified with diabetes mellitus whose most recent diastolic BP is less than 90 mm Hg |
| Smoking cessation advice (45–69 years) |
| % of population who have their smoking status recorded |
| % of population who are current smokers and have received smoking cessation advice |
| % of those with a diagnosis of IHD who have their smoking status recorded |
| % of those with a diagnosis of IHD who are current smokers who have received smoking cessation advice |
| % of those with a diagnosis of ischaemic stroke or TIA who have their smoking status recorded |
| % of those with a diagnosis of ischaemic stroke or TIA who are current smokers who have received smoking cessation advice |
| The use of angiotensin converting enzyme (ACE) inhibitors in those with heart failure (45–74 years) |
| % of population with a diagnosis of heart failure |
| % of population with heart failure who have a prescription for ACE inhibitors |
| Lipid lowering drugs for patients with established cardiovascular disease (45–69 years) |
| % of those with a diagnosis of IHD who have had a cholesterol measurement |
| % of those with a diagnosis of IHD with a raised cholesterol who are prescribed lipid lowering drugs |
| Warfarin or aspirin for stroke prophylaxis in non valvular atrial fibrillation (NVAF) (45–74 years) |
| % of population with a diagnosis of NVAF |
| % of those with a diagnosis of NVAF who have a prescription for anticoagulants or aspirin |